Evidence map›Paper›PMID 42072696›Full record

ArticleBiomolecules2026

Recombinant Attenuated

Wenjing Li, Yu-An Li, Xiaolong Liu, Haiping Xie, Jingyi Zhao, Yi Feng, Huoying Shi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenjing LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Yu-An LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Xiaolong LiuCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Haiping XieCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Jingyi ZhaoCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Yi FengCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Huoying ShiCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.

Funding

Huoying Shi National Key R&D Program of China: 2023YFE0123500 and 2023YFD1800204-4Huoying Shi Natural Science Foundation of Jiangsu Province (BK20230576)Huoying Shi The National Natural Science Foundation of China (32302823, 32172802, 32002301, 31672516, 31172300, 30670079)Huoying Shi the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and supported by the 111 Project D18007Yu-an Li Jiangsu Excellent Postdoctoral Program (2023ZB275)
6 · The paper itself

Abstract

Necrotizing enteritis (NE) is an important intestinal disease threatening the poultry farming industry, and the ban on antibiotic growth promoters has created an urgent demand for safe and effective NE vaccines. Recombinant attenuated

Indexed as

Antigens, BacterialClostridium perfringensEnteritisPoultry DiseasesSalmonella enteritidisSalmonella Infections, AnimalAnimalsBacterial VaccinesChickensClostridium InfectionsGenetic VectorsHumansInterferon Regulatory Factor-3MaleMiceModels, MolecularAntigens, BacterialBacterial VaccinesInterferon Regulatory Factor-3Vaccines, AttenuatedEntB proteinimmunogenicitynecrotic enteritisSalmonella Enteritidis vectorvaccine development

Identifiers

PMID42072696
PMCPMC13115302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.